Related Experiment Video
Updated: Mar 30, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Sequential and Concurrent Chemoradiation: State of the Art
Nicole G Chau1, Robert I Haddad1
1Center for Head and Neck Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02115, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02115, USA; Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.
For locally advanced head and neck cancer, sequential and concurrent chemoradiation are standard treatments. Evolving strategies focus on deintensification for low-risk and intensification for high-risk patients.
Area of Science:
- Oncology
- Radiation Oncology
- Head and Neck Cancer Research
Background:
- Locally advanced head and neck cancer is common.
- Sequential and concurrent chemoradiation are standard curative-intent treatments.
- Debate persists regarding the optimal chemoradiation approach.
Purpose of the Study:
- To review current evidence on sequential versus concurrent chemoradiation for head and neck cancer.
- To discuss evolving treatment deintensification and intensification strategies.
- To highlight controversies and future research directions.
Main Methods:
- Literature review of recent evidence.
- Analysis of treatment paradigms in head and neck oncology.
- Discussion of therapeutic deintensification and intensification.
Main Results:
- Both sequential and concurrent chemoradiation are vital for treatment strategies.
- Treatment deintensification and intensification are key evolving concepts.
- Ongoing controversies necessitate further investigation.
Conclusions:
- Head and neck cancer management is shifting towards personalized therapy.
- Sequential and concurrent chemoradiation approaches are integral to these shifts.
- Further research is needed to refine optimal treatment strategies.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Treatment Resistant Cancers
Cancer Survival Analysis

